TEK and neoplasm: Recent studies have shown that altering angiogenesis through the Tie2 pathway or reducing glycolysis in tumor endothelial cells can normalize tumor vasculature, thus enhancing blood perfusion and drug delivery, and reducing tumor growth and metastasis15,16.